The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells (Q39699871)

14 September 2017

The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells (English)

1 reference

14 September 2017

0 references

Nina Kerk

1

1 reference

14 September 2017

Elwira A Strozyk

series ordinal

2

1 reference

14 September 2017

Birgit Pöppelmann

series ordinal

3

1 reference

14 September 2017

Stefan W Schneider

series ordinal

4

1 reference

14 September 2017

language of work or name

English

0 references

publication date

27 May 2010

1 reference

Journal of Investigative Dermatology

14 September 2017

1 reference

14 September 2017

130

1 reference

14 September 2017

9

1 reference

14 September 2017

2259-2268

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2010.136

14 September 2017

0 references

cites work

Antimetastatic effect of tinzaparin, a low-molecular-weight heparin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Signaling of the tissue factor coagulation pathway in angiogenesis and cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

The role of platelet activation in tumor metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

The heparins and cancer: review of clinical trials and biological properties

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Von Willebrand factor in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Molecular and cellular biology of von Willebrand factor

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Procoagulant mechanisms in tumour cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Effect of anticoagulant drugs in cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Procoagulant properties of human MV3 melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Secretion pores in human endothelial cells during acute hypoxia.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

A factor X-activating cysteine protease from malignant tissue

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Thrombomodulin: tumour biology and prognostic implications

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Delay of acute intracellular pH recovery after acidosis decreases endothelial cell activation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Immune modulation by melanoma-derived factors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Antithrombotic therapy and survival in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

The effect of low molecular weight heparin on survival in patients with advanced malignancy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

High Invasive Melanoma Cells Induce Matrix Metalloproteinase-1 Synthesis in Fibroblasts by Interleukin-1α and Basic Fibroblast Growth Factor-Mediated Mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Role of tissue factor in hemostasis, thrombosis, and vascular development

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Emerging roles of PAR-1 and PAFR in melanoma metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Mechanisms of heparin induced anti-cancer activity in experimental cancer models

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Tissue factor, thrombin, and cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Von Willebrand factor, platelets and endothelial cell interactions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Shear-induced unfolding triggers adhesion of von Willebrand factor fibers

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Affinity and kinetics of different heparins binding to P- and L-selectin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Role and regulation of the thrombin receptor (PAR-1) in human melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.136

7 January 2021

Identifiers

DOI

10.1038/JID.2010.136

1 reference

14 September 2017

1 reference